The growth of the Europe nonwoven products market is driven by rise in demand of nonwoven products to provide resistance to contamination and to offer better hygiene condition. Moreover, increase in usage of nonwoven products to avoid infections across all healthcare settings also drives the growth of the market.
Rise in efficiency in the prevention of hospital-acquired infections (HAIs), surge in pandemic outbreaks, and increase in geriatric population suffering from chronic diseases fuel the growth of the Europe nonwoven products market. By product, the sets segment held the major share in 2017. By end-user, the medical segment would remain lucrative by 2025.
The europe nonwoven products market size was valued at $1,529 million in 2017, and is projected to reach $2,940 million by 2025, registering a CAGR of 2.9% from 2021 to 2025.
Covid-19 scenario-
- Medical nonwoven products are extensively used in prevention of hospital acquired infections (HAIs) and management of incontinence conditions among patients, which in turn has impacted the Europe nonwoven products market positively.
- This likely to persist post pandemic as well, as the medical nonwoven products are usually used in surgical procedures, giving out as a blockade to microorganisms, and evade cross contamination.
The key market players analyzed in the Europe nonwoven products market report include Asahi Kasei Corporation, B. Braun Melsungen AG, Cardinal Health, Freudenberg & Co. KG, Hartmann Group, Zarys International Group, Investor AB (Mölnlycke Health Care AB), 3M Company, Kimberly-Clark Corporation, and Medline Industries, Inc. These market players have taken recourse to several strategies including partnership, expansion, collaboration, joint ventures, and others to prove their flair in the industry.
0 Comments